|
Product No.
|
Product Name
|
Size
|
| ALX-101-003-G001 |
beta-Alanine |
1 g |
| ALX-101-004-G025 |
L-Arginine |
25 g |
| ALX-101-005-G005 |
D-Arginine |
5 g |
| ALX-101-010-G001 |
L-Aspartic acid |
1 g |
| ALX-101-011-G001 |
D-Aspartic acid |
1 g |
| ALX-101-012-G010 |
L-Cysteine . hydrochloride |
10 g |
| ALX-101-016-G005 |
L-Glutamine |
5 g |
| ALX-101-017-G001 |
D-Glutamine |
1 g |
| ALX-101-018-G001 |
L-Glutamic acid |
1 g |
| ALX-101-019-G001 |
D-Glutamic acid |
1 g |
| ALX-101-036-G005 |
L-Ornithine . hydrochloride |
5 g |
| ALX-101-036-G025 |
L-Ornithine . hydrochloride |
25 g |
| ALX-101-037-G001 |
D-Ornithine . hydrochloride |
1 g |
| ALX-101-037-G005 |
D-Ornithine . hydrochloride |
5 g |
| ALX-101-051-G001 |
L-Tryptophan |
1 g |
| ALX-101-057-G010 |
L-Histidine . hydrochloride . monohydrate |
10 g |
| ALX-101-058-G001 |
D-Histidine . hydrochloride . monohydrate |
1 g |
| ALX-104-001-G005 |
Fmoc-Ala-OH |
5 g |
| ALX-104-001-G025 |
Fmoc-Ala-OH |
25 g |
| ALX-104-001-G100 |
Fmoc-Ala-OH |
100 g |
| ALX-104-002-G005 |
Fmoc-D-Ala-OH |
5 g |
| ALX-104-002-G025 |
Fmoc-D-Ala-OH |
25 g |
| ALX-104-004-G005 |
Fmoc-Arg(Mtr)-OH . IPE |
5 g |
| ALX-104-004-G025 |
Fmoc-Arg(Mtr)-OH . IPE |
25 g |
| ALX-104-006-G005 |
Fmoc-Arg(Pmc)-OH |
5 g |
| ALX-104-006-G025 |
Fmoc-Arg(Pmc)-OH |
25 g |
| ALX-104-008-G005 |
Fmoc-Asn-OH |
5 g |
| ALX-104-008-G025 |
Fmoc-Asn-OH |
25 g |
| ALX-104-008-G100 |
Fmoc-Asn-OH |
100 g |
| ALX-104-010-G005 |
Fmoc-Asn(Trt)-OH |
5 g |
| ALX-104-010-G025 |
Fmoc-Asn(Trt)-OH |
25 g |
| ALX-104-010-G100 |
Fmoc-Asn(Trt)-OH |
100 g |
| ALX-104-012-G001 |
Fmoc-Asp-OtBu |
1 g |
| ALX-104-012-G005 |
Fmoc-Asp-OtBu |
5 g |
| ALX-104-012-G025 |
Fmoc-Asp-OtBu |
25 g |
| ALX-104-013-G005 |
Fmoc-Asp(OBzl)-OH |
5 g |
| ALX-104-013-G025 |
Fmoc-Asp(OBzl)-OH |
25 g |
| ALX-104-014-G005 |
Fmoc-Asp(OtBu)-OH |
5 g |
| ALX-104-014-G025 |
Fmoc-Asp(OtBu)-OH |
25 g |
| ALX-104-014-G100 |
Fmoc-Asp(OtBu)-OH |
100 g |
| ALX-104-015-G001 |
Fmoc-D-Asp(OtBu)-OH |
1 g |
| ALX-104-015-G005 |
Fmoc-D-Asp(OtBu)-OH |
5 g |
| ALX-104-015-G025 |
Fmoc-D-Asp(OtBu)-OH |
25 g |
| ALX-104-016-G005 |
Fmoc-Cys(Acm)-OH |
5 g |
| ALX-104-016-G025 |
Fmoc-Cys(Acm)-OH |
25 g |
| ALX-104-016-G100 |
Fmoc-Cys(Acm)-OH |
100 g |
| ALX-104-018-G005 |
Fmoc-Cys(tBu)-OH |
5 g |
| ALX-104-018-G025 |
Fmoc-Cys(tBu)-OH |
25 g |
| ALX-104-018-G100 |
Fmoc-Cys(tBu)-OH |
100 g |
| ALX-104-021-G005 |
Fmoc-Cys(Trt)-OH |
5 g |
| ALX-104-021-G025 |
Fmoc-Cys(Trt)-OH |
25 g |
| ALX-104-021-G100 |
Fmoc-Cys(Trt)-OH |
100 g |
| ALX-104-022-G005 |
Fmoc-Gln-OH |
5 g |
| ALX-104-022-G025 |
Fmoc-Gln-OH |
25 g |
| ALX-104-022-G100 |
Fmoc-Gln-OH |
100 g |
| ALX-104-024-G005 |
Fmoc-Gln(Trt)-OH |
5 g |
| ALX-104-024-G025 |
Fmoc-Gln(Trt)-OH |
25 g |
| ALX-104-024-G100 |
Fmoc-Gln(Trt)-OH |
100 g |
| ALX-104-026-G001 |
Fmoc-Glu-OtBu |
1 g |
| ALX-104-026-G005 |
Fmoc-Glu-OtBu |
5 g |
| ALX-104-026-G025 |
Fmoc-Glu-OtBu |
25 g |
| ALX-104-027-G005 |
Fmoc-Glu(OBzl)-OH |
5 g |
| ALX-104-027-G025 |
Fmoc-Glu(OBzl)-OH |
25 g |
| ALX-104-028-G005 |
Fmoc-Glu(OtBu)-OH |
5 g |
| ALX-104-028-G025 |
Fmoc-Glu(OtBu)-OH |
25 g |
| ALX-104-028-G100 |
Fmoc-Glu(OtBu)-OH |
100 g |
| ALX-104-029-G001 |
Fmoc-D-Glu(OtBu)-OH |
1 g |
| ALX-104-029-G005 |
Fmoc-D-Glu(OtBu)-OH |
5 g |
| ALX-104-029-G025 |
Fmoc-D-Glu(OtBu)-OH |
25 g |
| ALX-104-030-G005 |
Fmoc-Gly-OH |
5 g |
| ALX-104-030-G025 |
Fmoc-Gly-OH |
25 g |
| ALX-104-030-G100 |
Fmoc-Gly-OH |
100 g |
| ALX-104-033-G005 |
Fmoc-His(Trt)-OH |
5 g |
| ALX-104-033-G025 |
Fmoc-His(Trt)-OH |
25 g |
| ALX-104-033-G100 |
Fmoc-His(Trt)-OH |
100 g |
| ALX-104-034-G005 |
Fmoc-D-His(Trt)-OH |
5 g |
| ALX-104-034-G025 |
Fmoc-D-His(Trt)-OH |
25 g |
| ALX-104-036-G005 |
Fmoc-Ile-OH |
5 g |
| ALX-104-036-G025 |
Fmoc-Ile-OH |
25 g |
| ALX-104-036-G100 |
Fmoc-Ile-OH |
100 g |
| ALX-104-037-G005 |
Fmoc-Leu-OH |
5 g |
| ALX-104-037-G025 |
Fmoc-Leu-OH |
25 g |
| ALX-104-037-G100 |
Fmoc-Leu-OH |
100 g |
| ALX-104-038-G005 |
Fmoc-D-Leu-OH |
5 g |
| ALX-104-038-G025 |
Fmoc-D-Leu-OH |
25 g |
| ALX-104-040-G005 |
Fmoc-Lys(Boc)-OH |
5 g |
| ALX-104-040-G025 |
Fmoc-Lys(Boc)-OH |
25 g |
| ALX-104-040-G100 |
Fmoc-Lys(Boc)-OH |
100 g |
| ALX-104-041-G001 |
Fmoc-D-Lys(Boc)-OH |
1 g |
| ALX-104-041-G005 |
Fmoc-D-Lys(Boc)-OH |
5 g |
| ALX-104-041-G025 |
Fmoc-D-Lys(Boc)-OH |
25 g |
| ALX-104-043-G005 |
Fmoc-Lys(Fmoc)-OH |
5 g |
| ALX-104-043-G025 |
Fmoc-Lys(Fmoc)-OH |
25 g |
| ALX-104-044-G005 |
Fmoc-Met-OH |
5 g |
| ALX-104-044-G025 |
Fmoc-Met-OH |
25 g |
| ALX-104-044-G100 |
Fmoc-Met-OH |
100 g |
| ALX-104-045-G005 |
Fmoc-D-Met-OH |
5 g |
| ALX-104-045-G025 |
Fmoc-D-Met-OH |
25 g |
| ALX-104-048-G005 |
Fmoc-Nle-OH |
5 g |
| ALX-104-048-G025 |
Fmoc-Nle-OH |
25 g |
| ALX-104-052-G005 |
Fmoc-Orn(Boc)-OH |
5 g |
| ALX-104-052-G025 |
Fmoc-Orn(Boc)-OH |
25 g |
| ALX-104-053-G005 |
Fmoc-Phe-OH |
5 g |
| ALX-104-053-G025 |
Fmoc-Phe-OH |
25 g |
| ALX-104-053-G100 |
Fmoc-Phe-OH |
100 g |
| ALX-104-054-G005 |
Fmoc-D-Phe-OH |
5 g |
| ALX-104-054-G025 |
Fmoc-D-Phe-OH |
25 g |
| ALX-104-059-G005 |
Fmoc-Pro-OH . H2O |
5 g |
| ALX-104-059-G025 |
Fmoc-Pro-OH . H2O |
25 g |
| ALX-104-059-G100 |
Fmoc-Pro-OH . H2O |
100 g |
| ALX-104-060-G005 |
Fmoc-D-Pro-OH |
5 g |
| ALX-104-060-G025 |
Fmoc-D-Pro-OH |
25 g |
| ALX-104-065-G005 |
Fmoc-Ser(tBu)-OH |
5 g |
| ALX-104-065-G025 |
Fmoc-Ser(tBu)-OH |
25 g |
| ALX-104-065-G100 |
Fmoc-Ser(tBu)-OH |
100 g |
| ALX-104-066-G001 |
Fmoc-D-Ser(tBu)-OH |
1 g |
| ALX-104-066-G005 |
Fmoc-D-Ser(tBu)-OH |
5 g |
| ALX-104-066-G025 |
Fmoc-D-Ser(tBu)-OH |
25 g |
| ALX-104-067-G005 |
Fmoc-Ser(Trt)-OH |
5 g |
| ALX-104-067-G025 |
Fmoc-Ser(Trt)-OH |
25 g |
| ALX-104-067-G100 |
Fmoc-Ser(Trt)-OH |
100 g |
| ALX-104-071-G005 |
Fmoc-Thr(tBu)-OH |
5 g |
| ALX-104-071-G025 |
Fmoc-Thr(tBu)-OH |
25 g |
| ALX-104-071-G100 |
Fmoc-Thr(tBu)-OH |
100 g |
| ALX-104-072-G001 |
Fmoc-D-Thr(tBu)-OH |
1 g |
| ALX-104-072-G005 |
Fmoc-D-Thr(tBu)-OH |
5 g |
| ALX-104-072-G025 |
Fmoc-D-Thr(tBu)-OH |
25 g |
| ALX-104-073-G005 |
Fmoc-Trp-OH |
5 g |
| ALX-104-073-G025 |
Fmoc-Trp-OH |
25 g |
| ALX-104-073-G100 |
Fmoc-Trp-OH |
100 g |
| ALX-104-074-G005 |
Fmoc-D-Trp-OH |
5 g |
| ALX-104-074-G025 |
Fmoc-D-Trp-OH |
25 g |
| ALX-104-075-G005 |
Fmoc-Trp(Boc)-OH |
5 g |
| ALX-104-075-G025 |
Fmoc-Trp(Boc)-OH |
25 g |
| ALX-104-075-G100 |
Fmoc-Trp(Boc)-OH |
100 g |
| ALX-104-078-G005 |
Fmoc-Tyr(tBu)-OH |
5 g |
| ALX-104-078-G025 |
Fmoc-Tyr(tBu)-OH |
25 g |
| ALX-104-078-G100 |
Fmoc-Tyr(tBu)-OH |
100 g |
| ALX-104-081-G005 |
Fmoc-Val-OH |
5 g |
| ALX-104-081-G025 |
Fmoc-Val-OH |
25 g |
| ALX-104-081-G100 |
Fmoc-Val-OH |
100 g |
| ALX-104-083-G005 |
Fmoc-D-Val-OH |
5 g |
| ALX-104-083-G025 |
Fmoc-D-Val-OH |
25 g |
| ALX-104-086-G001 |
Fmoc-D-Cys(Trt)-OH |
1 g |
| ALX-104-086-G005 |
Fmoc-D-Cys(Trt)-OH |
5 g |
| ALX-104-092-G005 |
Fmoc-Thr(Trt)-OH |
5 g |
| ALX-104-092-G025 |
Fmoc-Thr(Trt)-OH |
25 g |
| ALX-104-111-G005 |
Fmoc-Arg(Pbf)-OH |
5 g |
| ALX-104-111-G025 |
Fmoc-Arg(Pbf)-OH |
25 g |
| ALX-104-111-G100 |
Fmoc-Arg(Pbf)-OH |
100 g |
| ALX-104-113-G001 |
Fmoc-D-Arg(Pbf)-OH |
1 g |
| ALX-104-113-G005 |
Fmoc-D-Arg(Pbf)-OH |
5 g |
| ALX-104-113-G025 |
Fmoc-D-Arg(Pbf)-OH |
25 g |
| ALX-105-001-G005 |
NG-Nitro-L-arginine |
5 g |
| ALX-105-001-G025 |
NG-Nitro-L-arginine |
25 g |
| ALX-105-002-G001 |
NG-Nitro-D-arginine |
1 g |
| ALX-105-002-M250 |
NG-Nitro-D-arginine |
250 mg |
| ALX-105-003-G005 |
L-NAME . hydrochloride |
5 g |
| ALX-105-003-G025 |
L-NAME . hydrochloride |
25 g |
| ALX-105-004-G001 |
D-NAME . hydrochloride |
1 g |
| ALX-105-004-G005 |
D-NAME . hydrochloride |
5 g |
| ALX-105-004-M250 |
D-NAME . hydrochloride |
250 mg |
| ALX-105-005-G001 |
N-Acetyl-L-cysteine |
1 g |
| ALX-105-005-G005 |
N-Acetyl-L-cysteine |
5 g |
| ALX-105-009-M010 |
N-Methyl-D-aspartic acid |
10 mg |
| ALX-105-009-M050 |
N-Methyl-D-aspartic acid |
50 mg |
| ALX-105-009-M250 |
N-Methyl-D-aspartic acid |
250 mg |
| ALX-105-010-M050 |
N-Methyl-L-aspartic acid |
50 mg |
| ALX-105-010-M250 |
N-Methyl-L-aspartic acid |
250 mg |
| ALX-106-001-G001 |
L-NMMA . monoacetate |
1 g |
| ALX-106-001-M005 |
L-NMMA . monoacetate |
5 mg |
| ALX-106-001-M025 |
L-NMMA . monoacetate |
25 mg |
| ALX-106-001-M100 |
L-NMMA . monoacetate |
100 mg |
| ALX-106-002-M005 |
D-NMMA . monoacetate |
5 mg |
| ALX-106-002-M025 |
D-NMMA . monoacetate |
25 mg |
| ALX-106-002-M100 |
D-NMMA . monoacetate |
100 mg |
| ALX-106-003-G005 |
L-Citrulline |
5 g |
| ALX-106-004-M005 |
NG-Hydroxy-L-arginine . monoacetate |
5 mg |
| ALX-106-004-M025 |
NG-Hydroxy-L-arginine . monoacetate |
25 mg |
| ALX-106-005-M005 |
NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p’-sulfonate) |
5 mg |
| ALX-106-005-M025 |
NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p’-sulfonate) |
25 mg |
| ALX-106-006-M005 |
NG, NG-Dimethyl-L-arginine . dihydrochloride |
5 mg |
| ALX-106-006-M025 |
NG, NG-Dimethyl-L-arginine . dihydrochloride |
25 mg |
| ALX-106-007-M005 |
NG, N’G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p’-sulfonate) |
5 mg |
| ALX-106-007-M025 |
NG, N’G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p’-sulfonate) |
25 mg |
| ALX-106-008-M005 |
NG, N’G-Dimethyl-L-arginine . dihydrochloride |
5 mg |
| ALX-106-008-M025 |
NG, N’G-Dimethyl-L-arginine . dihydrochloride |
25 mg |
| ALX-106-010-M005 |
NG-Monoethyl-L-arginine . monoacetate |
5 mg |
| ALX-106-010-M025 |
NG-Monoethyl-L-arginine . monoacetate |
25 mg |
| ALX-106-011-M005 |
NG-Monomethyl-L-homoarginine . monoacetate |
5 mg |
| ALX-106-011-M025 |
NG-Monomethyl-L-homoarginine . monoacetate |
25 mg |
| ALX-106-012-M010 |
S-Methyl-L-thiocitrulline . dihydrochloride |
10 mg |
| ALX-106-012-M050 |
S-Methyl-L-thiocitrulline . dihydrochloride |
50 mg |
| ALX-106-013-M010 |
L-Thiocitrulline . dihydrochloride |
10 mg |
| ALX-106-013-M050 |
L-Thiocitrulline . dihydrochloride |
50 mg |
| ALX-106-014-M005 |
NG-Amino-L-arginine . hydrochloride |
5 mg |
| ALX-106-015-G001 |
L-allo-Isoleucine |
1 g |
| ALX-106-016-G001 |
D-allo-Isoleucine |
1 g |
| ALX-106-017-M050 |
L-Pipecolic acid . hydrochloride |
50 mg |
| ALX-106-020-G001 |
3-Nitro-L-tyrosine |
1 g |
| ALX-106-020-G005 |
3-Nitro-L-tyrosine |
5 g |
| ALX-106-023-M500 |
5-Hydroxy-L-tryptophan |
500 mg |
| ALX-106-024-G001 |
O-Phospho-L-serine |
1 g |
| ALX-106-025-G010 |
gamma-Aminobutyric acid |
10 g |
| ALX-106-026-M050 |
L-alpha-Aminoadipic acid |
50 mg |
| ALX-106-026-M250 |
L-alpha-Aminoadipic acid |
250 mg |
| ALX-106-027-M050 |
D-alpha-Aminoadipic acid |
50 mg |
| ALX-106-027-M250 |
D-alpha-Aminoadipic acid |
250 mg |
| ALX-106-028-M050 |
D-Cycloserine |
50 mg |
| ALX-106-028-M250 |
D-Cycloserine |
250 mg |
| ALX-106-030-G001 |
p-Chloro-DL-phenylalanine |
1 g |
| ALX-106-031-M050 |
p-Chloro-L-phenylalanine |
50 mg |
| ALX-106-031-M250 |
p-Chloro-L-phenylalanine |
250 mg |
| ALX-106-035-G001 |
4-Hydroxy-D-phenylglycine |
1 g |
| ALX-106-037-M025 |
L-Cycloserine |
25 mg |
| ALX-106-037-M100 |
L-Cycloserine |
100 mg |
| ALX-120-002-G005 |
2-Chlorotritylchloride resin |
5 g |
| ALX-120-002-G025 |
2-Chlorotritylchloride resin |
25 g |
| ALX-120-002-G100 |
2-Chlorotritylchloride resin |
100 g |
| ALX-121-002-G100 |
TBTU |
100 g |
| ALX-121-002-G250 |
TBTU |
250 g |
| ALX-121-002-G500 |
TBTU |
500 g |
| ALX-121-003-G100 |
HBTU |
100 g |
| ALX-121-003-G250 |
HBTU |
250 g |
| ALX-121-003-G500 |
HBTU |
500 g |
| ALX-123-001-G005 |
Fmoc-Amide-Linker |
5 g |
| ALX-123-010-G001 |
beta-(S-p-Methoxybenzyl)-beta,beta-cyclopentamethylene-propionic acid |
1 g |
| ALX-123-010-G005 |
beta-(S-p-Methoxybenzyl)-beta,beta-cyclopentamethylene-propionic acid |
5 g |
| ALX-151-001-PC01 |
beta-Amyloid (1-43) |
0.1 mg* |
| ALX-151-001-PC05 |
beta-Amyloid (1-43) |
0.5 mg* |
| ALX-151-002-P001 |
beta-Amyloid (1-42) |
1 mg* |
| ALX-151-002-PC05 |
beta-Amyloid (1-42) |
0.5 mg* |
| ALX-151-003-P001 |
beta-Amyloid (1-40) |
1 mg* |
| ALX-151-003-PC05 |
beta-Amyloid (1-40) |
0.5 mg* |
| ALX-151-005-P001 |
beta-Amyloid (1-28) |
1 mg* |
| ALX-151-005-PC05 |
beta-Amyloid (1-28) |
0.5 mg* |
| ALX-151-007-P001 |
［Gln11］-beta-Amyloid (1-16) |
1 mg* |
| ALX-151-007-PC05 |
［Gln11］-beta-Amyloid (1-16) |
0.5 mg* |
| ALX-151-008-P001 |
beta-Amyloid (25-35) |
1 mg* |
| ALX-151-008-P005 |
beta-Amyloid (25-35) |
5 mg* |
| ALX-151-009-P001 |
beta-Amyloid (10-20) |
1 mg* |
| ALX-151-009-P005 |
beta-Amyloid (10-20) |
5 mg* |
| ALX-151-011-P001 |
beta-Amyloid / A4 Protein Precursor ［APP］ (328-332) |
1 mg* |
| ALX-151-011-P005 |
beta-Amyloid / A4 Protein Precursor ［APP］ (328-332) |
5 mg* |
| ALX-151-013-MC05 |
Apamin |
0.5 mg |
| ALX-151-014-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-24) |
1 mg |
| ALX-151-014-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-24) |
0.5 mg |
| ALX-151-016-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-22) amide |
1 mg |
| ALX-151-016-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-22) amide |
0.5 mg |
| ALX-151-017-M001 |
cAMP-dependent Protein Kinase Inhibitor (14-24) amide |
1 mg |
| ALX-151-017-M005 |
cAMP-dependent Protein Kinase Inhibitor (14-24) amide |
5 mg |
| ALX-151-018-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-24) amide |
1 mg |
| ALX-151-018-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-24) amide |
0.5 mg |
| ALX-151-019-M001 |
cAMP-dependent Protein Kinase Substrate |
1 mg |
| ALX-151-019-MC05 |
cAMP-dependent Protein Kinase Substrate |
0.5 mg |
| ALX-151-020-M010 |
N-Acetyl-Asp-Glu-OH |
10 mg |
| ALX-151-020-M050 |
N-Acetyl-Asp-Glu-OH |
50 mg |
| ALX-151-021-M001 |
H-Arg-Gly-Tyr-Ser-Leu-Gly-OH |
1 mg |
| ALX-151-021-M005 |
H-Arg-Gly-Tyr-Ser-Leu-Gly-OH |
5 mg |
| ALX-151-022-M001 |
H-Arg-Gly-Tyr-Ala-Leu-Gly-OH |
1 mg |
| ALX-151-022-M005 |
H-Arg-Gly-Tyr-Ala-Leu-Gly-OH |
5 mg |
| ALX-151-023-M001 |
Autocamtide-2 |
1 mg |
| ALX-151-023-M005 |
Autocamtide-2 |
5 mg |
| ALX-151-024-M001 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH |
1 mg |
| ALX-151-024-M005 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH |
5 mg |
| ALX-151-026-M001 |
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 |
1 mg |
| ALX-151-027-M001 |
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 |
1 mg |
| ALX-151-028-M001 |
Protein Tyrosine Kinase pp60c-src Substrate |
1 mg |
| ALX-151-028-M005 |
Protein Tyrosine Kinase pp60c-src Substrate |
5 mg |
| ALX-151-029-M001 |
Autocamtide-2-Related Inhibitory Peptide |
1 mg |
| ALX-151-029-M005 |
Autocamtide-2-Related Inhibitory Peptide |
5 mg |
| ALX-151-030-MC05 |
Autocamtide-2-Related Inhibitory Peptide (Myristoylated) |
0.5 mg |
| ALX-151-031-M001 |
Caspase-3 Control Peptide |
1 mg |
| ALX-151-031-M005 |
Caspase-3 Control Peptide |
5 mg |
| ALX-151-033-C050 |
Blocking Peptide for?PAb to Androgen Receptor (Prod. No. ALX-210-152) |
50.micro.g |
| ALX-151-034-C050 |
Blocking Peptide for?PAb to?AIB1 (Prod. No. ALX-210-255) |
50.micro.g |
| ALX-151-035-M001 |
Ac-muramyl-Ala-D-Glu-amide |
1 mg |
| ALX-151-035-M005 |
Ac-muramyl-Ala-D-Glu-amide |
5 mg |
| ALX-151-036-M001 |
Ac-muramyl-D-Ala-D-Glu-amide |
1 mg |
| ALX-151-036-M005 |
Ac-muramyl-D-Ala-D-Glu-amide |
5 mg |
| ALX-152-001-P001 |
Big Endothelin-1 (1-38) (human) |
1 mg* |
| ALX-152-001-PC01 |
Big Endothelin-1 (1-38) (human) |
0.1 mg* |
| ALX-152-001-PC05 |
Big Endothelin-1 (1-38) (human) |
0.5 mg* |
| ALX-152-002-PC01 |
Big Endothelin-1 (1-39) (pig) |
0.1 mg* |
| ALX-152-002-PC05 |
Big Endothelin-1 (1-39) (pig) |
0.5 mg* |
| ALX-152-003-PC01 |
Big Endothelin-1 (1-39) (rat) |
0.1 mg* |
| ALX-152-003-PC05 |
Big Endothelin-1 (1-39) (rat) |
0.5 mg* |
| ALX-152-004-PC01 |
Big Endothelin-2 (1-37) (human) |
0.1 mg* |
| ALX-152-004-PC05 |
Big Endothelin-2 (1-37) (human) |
0.5 mg* |
| ALX-152-006-M005 |
Bradykinin |
5 mg |
| ALX-152-006-M025 |
Bradykinin |
25 mg |
| ALX-152-007-PC01 |
Big Endothelin-1 (1-39) (bovine) |
0.1 mg* |
| ALX-152-007-PC05 |
Big Endothelin-1 (1-39) (bovine) |
0.5 mg* |
| ALX-152-012-M001 |
Big Endothelin-1 (22-38) (human) |
1 mg |
| ALX-152-012-MC05 |
Big Endothelin-1 (22-38) (human) |
0.5 mg |
| ALX-152-014-M001 |
Big Endothelin-1 (19-37) (human), ［Phe22］- |
1 mg |
| ALX-152-014-MC05 |
Big Endothelin-1 (19-37) (human), ［Phe22］- |
0.5 mg |
| ALX-152-018-P001 |
Bombesin |
1 mg* |
| ALX-152-018-P005 |
Bombesin |
5 mg* |
| ALX-152-022-M001 |
BPDEtide |
1 mg |
| ALX-152-022-M005 |
BPDEtide |
5 mg |
| ALX-152-023-C050 |
Blocking Peptide for?PAb to?Ah Receptor Nuclear Translocator?3 (Prod. No. ALX-210-245) |
50.micro.g |
| ALX-152-027-1 |
BimL (147-164) (human) (cell-permeable) |
1 Vial |
| ALX-152-028-1 |
Bax (58-75) (human) (cell-permeable) |
1 Vial |
| ALX-152-029-1 |
Bok (66-83) (human) (cell-permeable) |
1 Vial |
| ALX-153-001-M001 |
Calcitonin (salmon) |
1 mg |
| ALX-153-001-MC05 |
Calcitonin (salmon) |
0.5 mg |
| ALX-153-003-M001 |
Casein Kinase II Substrate |
1 mg |
| ALX-153-003-M005 |
Casein Kinase II Substrate |
5 mg |
| ALX-153-006-M001 |
Ca2+ / Calmodulin-dependent Protein Kinase II (290-309) |
1 mg |
| ALX-153-006-MC01 |
Ca2+ / Calmodulin-dependent Protein Kinase II (290-309) |
0.1 mg |
| ALX-153-008-M001 |
Ca2+ / Calmodulin-dependent Protein Kinase IV Substrate |
1 mg |
| ALX-153-008-M005 |
Ca2+ / Calmodulin-dependent Protein Kinase IV Substrate |
5 mg |
| ALX-153-009-M001 |
Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) |
1 mg |
| ALX-153-009-M005 |
Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) |
5 mg |
| ALX-153-010-M001 |
［Ala286］-Ca2+ / Calmodulin-dependent Protein Kinase II (281-302) |
1 mg |
| ALX-153-010-MC01 |
［Ala286］-Ca2+ / Calmodulin-dependent Protein Kinase II (281-302) |
0.1 mg |
| ALX-153-012-M001 |
Cyclin-dependent Kinase 2 Inhibitor |
1 mg |
| ALX-153-012-M005 |
Cyclin-dependent Kinase 2 Inhibitor |
5 mg |
| ALX-153-016-C050 |
Blocking Peptide for Antiserum to Calreticulin (CT) (Prod. No. ALX-210-171) |
50.micro.g |
| ALX-153-017-C050 |
Blocking Peptide for Antiserum to Calreticulin (NT) (Prod. No. ALX-210-170) |
50.micro.g |
| ALX-153-018-M005 |
［Ala288］-Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) |
5 mg |
| ALX-153-019-C100 |
Blocking Peptide for?PAb to CCR1 (human) (Prod. No. ALX-210-741) |
100.micro.g |
| ALX-153-020-C100 |
Blocking Peptide for PAb to CCR4 (mouse) (Prod. No. ALX-210-742) |
100.micro.g |
| ALX-153-021-M001 |
Calcitonin (human) |
1 mg |
| ALX-153-021-MC05 |
Calcitonin (human) |
0.5 mg |
| ALX-153-023-C050 |
Blocking Peptide for?PAb to CREB Binding Protein (human) (Prod. No. ALX-210-229) |
50.micro.g |
| ALX-153-024-C100 |
Blocking Peptide for?PAb?to CCR8 (human) (Prod. No. ALX-210-762) |
100.micro.g |
| ALX-153-025-C100 |
Blocking Peptide for?PAb to CCR8 (human)?(Prod. No. ALX-210-764) |
100.micro.g |
| ALX-153-028-C050 |
Blocking Peptide for?PAb to Cyclophilin B (Prod. No. ALX-210-237) |
50.micro.g |
| ALX-153-029-C050 |
Blocking Peptide for?PAb to Caveolin-2 (rat) (Prod. No. ALX-210-240) |
50.micro.g |
| ALX-153-030-C050 |
Blocking Peptide for?PAb to Caveolin-3 (rat) (Prod. No. ALX-210-241) |
50.micro.g |
| ALX-153-031-C050 |
Blocking Peptide for?PAb to CLOCK (NT) (Prod. No. ALX-210-243) |
50.micro.g |
| ALX-153-032-C050 |
Blocking Peptide for?PAb to CLOCK (mouse) (CT) (Prod. No. ALX-210-244) |
50.micro.g |
| ALX-153-033-C050 |
Blocking Peptide for PAb to Cyclophilin D (Prod. No. ALX-210-789) |
50.micro.g |
| ALX-153-034-C100 |
Blocking Peptide for?PAb to CXCR4 (mouse) (Prod. No. ALX-210-819) |
100.micro.g |
| ALX-153-035-C100 |
Blocking Peptide for?PAb to CXCR4 (human) (Prod. No. ALX-210-820) |
100.micro.g |
| ALX-153-036-C100 |
Blocking Peptide for?PAb to CCR2 (human) (Prod. No. ALX-210-821) |
100.micro.g |
| ALX-153-037-C100 |
Blocking Peptide for PAb?to CCR3 (human) (Prod. No. ALX-210-822) |
100.micro.g |
| ALX-153-039-C100 |
Blocking Peptide for?PAb to CCR5 (human) (Prod. No. ALX-210-823) |
100.micro.g |
| ALX-153-041-C500 |
Cyclin-dependent Kinase 2 Inhibitory Peptide I |
500.micro.g |
| ALX-153-042-C500 |
Cyclin-dependent Kinase 2 Inhibitory Peptide II |
500.micro.g |
| ALX-153-043-C100 |
Blocking Peptide for?PAb tobeta-Chemokine Receptor D6 (human) (Prod. No. ALX-210-839) |
100.micro.g |
| ALX-153-044-C100 |
Blocking Peptide for?PAb to Caspase-14 (mouse) (Prod. No. ALX-210-842) |
100.micro.g |
| ALX-153-045-C100 |
Blocking Peptide for?PAb to CCR6 (human) (Prod. No. ALX-210-843) |
100.micro.g |
| ALX-153-046-C100 |
Blocking Peptide for?PAb to CCR7 (Prod. No. ALX-210-844) |
100.micro.g |
| ALX-153-047-C100 |
Blocking Peptide for?PAb to CCR8 (mouse) (Prod. No. ALX-210-845) |
100.micro.g |
| ALX-153-048-C100 |
Blocking Peptide for?PAb to CCR9 (Prod. No. ALX-210-846) |
100.micro.g |
| ALX-153-049-C100 |
Blocking Peptide for?PAb to CCR9 (human) (Prod. No. ALX-210-847) |
100.micro.g |
| ALX-153-050-C100 |
Blocking Peptide for?PAb to CCR10 (mouse) (Prod. No. ALX-210-848) |
100.micro.g |
| ALX-153-051-C100 |
Blocking Peptide for?PAb to CCR10 (human) (Prod. No. ALX-210-849) |
100.micro.g |
| ALX-153-053-C100 |
Blocking Peptide for?PAb to beta-Chemokine Receptor D6 (mouse) (Prod. No. ALX-210-851) |
100.micro.g |
| ALX-153-054-C050 |
Blocking Peptide for?PAb to Caveolin-1 (Prod. No. ALX-210-347) |
50.micro.g |
| ALX-153-055-G001 |
Carnosine |
1 g |
| ALX-153-056-C050 |
Blocking Peptide for PAb to CHIP (human) (Prod. No. ALX-210-883) |
50.micro.g |
| ALX-153-057-C050 |
Blocking Peptide for PAb to alpha-COP (Prod. No. ALX-210-884) |
50.micro.g |
| ALX-153-058-C050 |
Blocking Peptide for PAb to beta-’-COP (rat) (Prod. No. ALX-210-886) |
50.micro.g |
| ALX-153-060-C050 |
Blocking Peptide for PAb to Caveolin-2 (phosphorylated) (pTyr19) (mouse) (Prod. No. ALX-210-888) |
50.micro.g |
| ALX-153-061-C100 |
Blocking Peptide for PAb to CCR4 (human) (Prod. No. ALX-210-622) |
100.micro.g |
| ALX-153-062-C050 |
Blocking Peptide for PAb to Caspase-3 (active) (Prod. No. 210-807) |
50.micro.g |
| ALX-153-063-C200 |
Blocking Peptide for PAb to COX-2 (mouse) (Prod. No. 210-711) |
200.micro.g |
| ALX-154-001-C050 |
Blocking Peptide for?PAb to Dynamin I ［Dyn1］ (rat) (Prod. No. ALX-210-207) |
50.micro.g |
| ALX-154-002-C050 |
Blocking Peptide for?PAb to Dynamin II ［Dyn2］ (Prod. No. ALX-210-262) |
50.micro.g |
| ALX-154-003-C050 |
Blocking Peptide for?PAb to Dynamin III ［Dyn3］ (Prod. No. ALX-210-263) |
50.micro.g |
| ALX-155-001-P001 |
Endothelin-1 (human, mouse rat, pig, bovine, dog) |
1 mg* |
| ALX-155-001-PC01 |
Endothelin-1 (human, mouse rat, pig, bovine, dog) |
0.1 mg* |
| ALX-155-001-PC05 |
Endothelin-1 (human, mouse rat, pig, bovine, dog) |
0.5 mg* |
| ALX-155-002-P001 |
Endothelin-2 (human, pig, dog) |
1 mg* |
| ALX-155-002-PC01 |
Endothelin-2 (human, pig, dog) |
0.1 mg* |
| ALX-155-002-PC05 |
Endothelin-2 (human, pig, dog) |
0.5 mg* |
| ALX-155-003-P001 |
Endothelin-3 (human, rat, pig) |
1 mg* |
| ALX-155-003-PC01 |
Endothelin-3 (human, rat, pig) |
0.1 mg* |
| ALX-155-003-PC05 |
Endothelin-3 (human, rat, pig) |
0.5 mg* |
| ALX-155-004-P001 |
ETA-Receptor Antagonist ［BQ-123］ . sodium salt |
1 mg* |
| ALX-155-004-P005 |
ETA-Receptor Antagonist ［BQ-123］ . sodium salt |
5 mg* |
| ALX-155-005-P001 |
ET-Receptor Antagonist ［BE-18257A］ |
1 mg* |
| ALX-155-005-PC05 |
ET-Receptor Antagonist ［BE-18257A］ |
0.5 mg* |
| ALX-155-006-P001 |
ETB-Receptor Agonist ［IRL-1620］ |
1 mg* |
| ALX-155-006-PC05 |
ETB-Receptor Agonist ［IRL-1620］ |
0.5 mg* |
| ALX-155-007-P001 |
ETB-Receptor Antagonist ［IRL-1038］ |
1 mg* |
| ALX-155-007-PC05 |
ETB-Receptor Antagonist ［IRL-1038］ |
0.5 mg* |
| ALX-155-008-P001 |
ET-Receptor Antagonist ［PD 142893］ |
1 mg* |
| ALX-155-008-PC05 |
ET-Receptor Antagonist ［PD 142893］ |
0.5 mg* |
| ALX-155-009-P001 |
ETA-Receptor Antagonist ［BE-18257B］ |
1 mg* |
| ALX-155-009-PC05 |
ETA-Receptor Antagonist ［BE-18257B］ |
0.5 mg* |
| ALX-155-010-P001 |
ETB-Receptor Agonist ［4 Ala ET-1］ |
1 mg* |
| ALX-155-010-PC05 |
ETB-Receptor Agonist ［4 Ala ET-1］ |
0.5 mg* |
| ALX-155-011-P001 |
ETA-Receptor Antagonist ［BQ-610］ |
1 mg* |
| ALX-155-011-P005 |
ETA-Receptor Antagonist ［BQ-610］ |
5 mg* |
| ALX-155-012-P001 |
ETA-Receptor Antagonist ［JKC-301］ |
1 mg* |
| ALX-155-012-PC05 |
ETA-Receptor Antagonist ［JKC-301］ |
0.5 mg* |
| ALX-155-013-P001 |
ETA-Receptor Antagonist ［JKC-302］ |
1 mg* |
| ALX-155-013-PC05 |
ETA-Receptor Antagonist ［JKC-302］ |
0.5 mg* |
| ALX-155-015-P001 |
ETB-Receptor Agonist ［BQ-3020］ |
1 mg* |
| ALX-155-015-PC05 |
ETB-Receptor Agonist ［BQ-3020］ |
0.5 mg* |
| ALX-155-016-P001 |
ET-Receptor Antagonist ［PD 145065］ |
1 mg* |
| ALX-155-016-PC05 |
ET-Receptor Antagonist ［PD 145065］ |
0.5 mg* |
| ALX-155-017-P001 |
ETA-Receptor Antagonist ［FR 139317］ |
1 mg* |
| ALX-155-017-PC05 |
ETA-Receptor Antagonist ［FR 139317］ |
0.5 mg* |
| ALX-155-018-M001 |
ETB-Receptor Antagonist ［RES-701-1］ |
1 mg |
| ALX-155-018-MC05 |
ETB-Receptor Antagonist ［RES-701-1］ |
0.5 mg |
| ALX-155-019-M001 |
ETB-Receptor Antagonist ［RES-701-3］ |
1 mg |
| ALX-155-019-MC05 |
ETB-Receptor Antagonist ［RES-701-3］ |
0.5 mg |
| ALX-155-020-M001 |
ETB-Receptor Antagonist ［BQ-788］ . sodium salt |
1 mg |
| ALX-155-020-MC05 |
ETB-Receptor Antagonist ［BQ-788］ . sodium salt |
0.5 mg |
| ALX-155-021-M001 |
EGF Receptor (human) (651-658) |
1 mg |
| ALX-155-021-M005 |
EGF Receptor (human) (651-658) |
5 mg |
| ALX-155-022-M001 |
EGF Receptor (human) (651-658) (N-Myristoylated) |
1 mg |
| ALX-155-022-M005 |
EGF Receptor (human) (651-658) (N-Myristoylated) |
5 mg |
| ALX-155-023-M001 |
EGF Receptor (human) (652-657) |
1 mg |
| ALX-155-023-M005 |
EGF Receptor (human) (652-657) |
5 mg |
| ALX-155-024-M001 |
ERT Protein Kinase Substrate |
1 mg |
| ALX-155-024-M005 |
ERT Protein Kinase Substrate |
5 mg |
| ALX-155-025-C050 |
Blocking Peptide for?PAb to Estrogen Receptor beta ［ERbeta］ (Prod. No. ALX-210-132) |
50.micro.g |
| ALX-155-026-M001 |
ERT Protein Kinase Substrate Amide |
1 mg |
| ALX-155-026-M005 |
ERT Protein Kinase Substrate Amide |
5 mg |
| ALX-155-027-C050 |
Blocking Peptide for?PAb to Estrogen Receptor beta ［ERbeta］ (Prod. No. ALX-210-135) |
50.micro.g |
| ALX-155-028-C050 |
Blocking Peptide for MAb to Estrogen Receptor alpha ［ERalpha］ (Prod. No. ALX-803-004) |
50.micro.g |
| ALX-155-029-C050 |
Blocking Peptide for?PAb to Estrogen Receptor beta ［ERbeta］ (human) (Prod. No. ALX-210-180) |
50.micro.g |
| ALX-155-030-C050 |
Blocking Peptide for PAb to Estrogen Receptor beta ［ERbeta］ (Prod. No. ALX-210-178) |
50.micro.g |
| ALX-155-031-C050 |
Blocking Peptide for?PAb to Estrogen Receptor alpha ［ERalpha (Prod. No. ALX-210-201) |
50.micro.g |
| ALX-155-032-C050 |
Blocking Peptide for?PAb to Estrogen Receptor alpha ［ERalpha］ (Prod. No. ALX-210-202) |
50.micro.g |
| ALX-155-033-C050 |
Blocking Peptide for?PAb to Early Endosomal Antigen 1?(Prod. No. ALX-210-239) |
50.micro.g |
| ALX-155-034-C050 |
Blocking Peptide for PAb to Epithelial Cell Sodium Channel gamma (rat) (Prod. No. ALX-210-299) |
50.micro.g |
| ALX-155-035-C050 |
Blocking Peptide for?PAb to Epithelial Cell Sodium Channel alpha?(rat)?(Prod. No. ALX-210-291) |
50.micro.g |
| ALX-155-036-C050 |
Blocking Peptide for?PAb to Epithelial Cell Sodium Channel beta? (rat) (Prod. No. ALX-210-300) |
50.micro.g |
| ALX-156-001-C050 |
Blocking Peptide for PAb to Furin Convertase (Prod. No. ALX-210-134) |
50.micro.g |
| ALX-156-002-C050 |
Blocking Peptide for?PAb to FKBP12 (Prod. No. ALX-210-142) |
50.micro.g |
| ALX-156-003-C050 |
Blocking Peptide for?PAb to FKBP51 (Prod. No. ALX-210-236) |
50.micro.g |
| ALX-156-004-C050 |
Blocking Peptide for PAb to FIAF (Prod. No. ALX-210-360) |
50.micro.g |
| ALX-156-005-C200 |
Blocking Peptide for PAb to Fatty Acid Amide Hydrolase ［FAAH］ (Prod. No. ALX-210-418) |
200.micro.g |
| ALX-157-001-G001 |
L-Glutathione (oxidized form) |
1 g |
| ALX-157-001-G005 |
L-Glutathione (oxidized form) |
5 g |
| ALX-157-001-M250 |
L-Glutathione (oxidized form) |
250 mg |
| ALX-157-002-G001 |
L-Glutathione (reduced form) |
1 g |
| ALX-157-002-G005 |
L-Glutathione (reduced form) |
5 g |
| ALX-157-002-G025 |
L-Glutathione (reduced form) |
25 g |
| ALX-157-003-P001 |
Galanin (human) |
1 mg* |
| ALX-157-003-PC05 |
Galanin (human) |
0.5 mg* |
| ALX-157-004-P001 |
Galanin (pig) |
1 mg* |
| ALX-157-004-PC05 |
Galanin (pig) |
0.5 mg* |
| ALX-157-010-M001 |
Guanylin (human) |
1 mg |
| ALX-157-010-MC01 |
Guanylin (human) |
0.1 mg |
| ALX-157-011-M001 |
Guanylin (rat, mouse) |
1 mg |
| ALX-157-011-MC01 |
Guanylin (rat, mouse) |
0.1 mg |
| ALX-157-013-M001 |
［Ala9,10, Lys11,12］-Glycogen Synthase (1-12) |
1 mg |
| ALX-157-013-M005 |
［Ala9,10, Lys11,12］-Glycogen Synthase (1-12) |
5 mg |
| ALX-157-014-M001 |
H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH |
1 mg |
| ALX-157-014-M005 |
H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH |
5 mg |
| ALX-157-015-C050 |
Blocking Peptide for?PAb to Glucocorticoid Receptor ［GR］ (Prod. No. ALX-210-131) |
50.micro.g |
| ALX-157-016-C050 |
Blocking Peptide for?PAb to Glucocorticoid Receptor ［GR］ (Prod. No. ALX-210-153) |
50.micro.g |
| ALX-157-018-C050 |
Blocking Peptide for?PAb to Green Fluorescent Protein (Prod. No. ALX-210-199) |
50.micro.g |
| ALX-157-019-C050 |
Blocking Peptide for PAb to Glucocorticoid Receptor Interacting Protein-1 (Prod. No. ALX-210-286) |
50.micro.g |
| ALX-157-020-MC01 |
Galanin Like Peptide ［GALP］ (1-60) (pig) |
0.1 mg |
| ALX-157-021-MC05 |
Ghrelin (human) |
0.5 mg |
| ALX-157-021-M001 |
Ghrelin (human) |
1 mg |
| ALX-157-022-MC05 |
Ghrelin (rat) |
0.5 mg |
| ALX-157-022-M001 |
Ghrelin (rat) |
1 mg |
| ALX-157-023-C200 |
Blocking Peptide for PAb to Guanylyl Cyclase beta1, Soluble (ALX-210-867) |
200.micro.g |
| ALX-157-024-C200 |
Blocking Peptide for PAb to Guanylyl Cyclase (alpha Subunit), Soluble (Prod. No. ALX-210-878) |
200.micro.g |
| ALX-158-001-M001 |
Histone H1-7 Substrate |
1 mg |
| ALX-158-001-M005 |
Histone H1-7 Substrate |
5 mg |
| ALX-158-002-M001 |
［Ala32］-Histone H2B (29-35) |
1 mg |
| ALX-158-002-M005 |
［Ala32］-Histone H2B (29-35) |
5 mg |
| ALX-158-003-M001 |
Histone H2B (29-35) |
1 mg |
| ALX-158-003-M005 |
Histone H2B (29-35) |
5 mg |
| ALX-158-004-M001 |
［Ala34］-Histone H2B (29-35) |
1 mg |
| ALX-158-004-M005 |
［Ala34］-Histone H2B (29-35) |
5 mg |
| ALX-158-005-M001 |
Hymenistatin |
1 mg |
| ALX-158-005-MC05 |
Hymenistatin |
0.5 mg |
| ALX-158-006-C050 |
Blocking Peptide for?PAb to Histone Deacetylase 1?(Prod. No. ALX-210-256) |
50.micro.g |
| ALX-158-007-C050 |
Blocking Peptide for?PAb to Histone Deacetylase 2 (Prod. No. ALX-210-257) |
50.micro.g |
| ALX-158-008-C050 |
Blocking Peptide for?PAb to Histone Deacetylase 3 (Prod. No. ALX-210-258) |
50.micro.g |
| ALX-158-009-C050 |
Blocking Peptide for PAb?to Histone Deacetylase 4?(human) (CT) (Prod. No. ALX-210-338) |
50.micro.g |
| ALX-158-011-MC05 |
Humanin (human) |
0.5 mg |
| ALX-158-011-M001 |
Humanin (human) |
1 mg |
| ALX-159-001-M001 |
IL-2 Receptor Fragment (human) |
1 mg |
| ALX-159-003-C050 |
Blocking Peptide for PAb?to Inositol-1,4,5-trisphosphate Receptor (Type-1) (Prod. No. ALX-210-115?& ALX-210-169) |
50.micro.g |
| ALX-159-004-C050 |
Blocking Peptide for?PAb to Inositol-1,4,5-trisphosphate Receptor (Type-II) (rat) (Prod. No. ALX-210-224) |
50.micro.g |
| ALX-159-005-C050 |
Blocking Peptide for?PAb to Inositol Hexakisphosphate ［IP6］ Kinase (rat) (Prod. No. ALX-210-289) |
50.micro.g |
| ALX-159-006-C100 |
Blocking Peptide for PAb to IL-21 (human) (C-terminal) (Prod. No. ALX-210-624) |
100.micro.g |
| ALX-159-007-C100 |
Blocking Peptide for PAb to IL-21 (human) (N-terminal) (Prod. No. ALX-210-625) |
100.micro.g |
| ALX-159-008-C100 |
Blocking Peptide for PAb to IL-21 (mouse) (C-terminal) (Prod. No. ALX-210-626) |
100.micro.g |
| ALX-159-009-C100 |
Blocking Peptide for PAb to IL-21 (mouse) (N-terminal) (Prod. No. ALX-210-627) |
100.micro.g |
| ALX-159-010-C100 |
Blocking Peptide for PAb to IL-22 (C-terminal) (Prod. No. ALX-210-628) |
100.micro.g |
| ALX-159-011-C100 |
Blocking Peptide for PAb to IL-22 (human) (N-terminal) (Prod. No. ALX-210-629) |
100.micro.g |
| ALX-159-012-C100 |
Blocking Peptide for PAb to IL-22 (mouse) (N-terminal) (Prod. No. ALX-210-630) |
100.micro.g |
| ALX-159-013-C100 |
Blocking Peptide for PAb to to IL-21 Receptor (human) (Prod. No. ALX-210-631) |
100.micro.g |
| ALX-159-014-C100 |
Blocking Peptide for PAb to IL-21 Receptor (mouse) (Prod. No. ALX-210-632) |
100.micro.g |
| ALX-159-015-C100 |
Blocking Peptide for PAb to to IL-22 Receptor-alpha 2 (human) (Prod. No. ALX-210-633) |
100.micro.g |
| ALX-159-016-C100 |
Blocking Peptide for PAb to IL-22 Receptor (human) (Prod. No. ALX-210-634) |
100.micro.g |
| ALX-159-017-C100 |
Blocking Peptide for PAb to IL-21 Receptor-alpha (mouse) (Prod. No. ALX-210-635) |
100.micro.g |
| ALX-159-600-R100 |
JNK Inhibitor 1 (L-stereoisomer) |
100.micro.l |
| ALX-159-600-R200 |
JNK Inhibitor 1 (L-stereoisomer) |
200.micro.l |
| ALX-160-002-M001 |
Kemptamide |
1 mg |
| ALX-160-002-M005 |
Kemptamide |
5 mg |
| ALX-160-006-M001 |
Kemptide |
1 mg |
| ALX-160-006-M005 |
Kemptide |
5 mg |
| ALX-160-008-M001 |
［Trp4］-Kemptide |
1 mg |
| ALX-160-008-M005 |
［Trp4］-Kemptide |
5 mg |
| ALX-160-009-C050 |
Blocking Peptide for?PAb to Kinesin-like Protein (mouse)?(Prod. No. ALX-210-203) |
50.micro.g |
| ALX-160-010-C050 |
Blocking Peptide for?PAb to Kinesin Motor?Protein (mouse) (Prod. No. ALX-210-204) |
50.micro.g |
| ALX-161-003-C050 |
Blocking Peptide for?PAb to Leptin Receptor?(Prod. No. ALX-210-168) |
50.micro.g |
| ALX-161-004-C050 |
Blocking Peptide for?PAb to Lysosome-Associated Membrane Protein-2 (Prod. No. ALX-210-206) |
, 50.micro.g |
| ALX-162-001-M001 |
Mastoparan |
1 mg |
| ALX-162-001-M005 |
Mastoparan |
5 mg |
| ALX-162-002-MC05 |
MCD Peptide |
0.5 mg |
| ALX-162-004-M001 |
MARCKS Protein (151-175) (bovine brain) |
1 mg |
| ALX-162-004-MC05 |
MARCKS Protein (151-175) (bovine brain) |
0.5 mg |
| ALX-162-005-M001 |
MARCKS Protein (159-165) amide (bovine brain) |
1 mg |
| ALX-162-005-M005 |
MARCKS Protein (159-165) amide (bovine brain) |
5 mg |
| ALX-162-006-M001 |
Melittin (natural) |
1 mg |
| ALX-162-006-M005 |
Melittin (natural) |
5 mg |
| ALX-162-007-M001 |
Melittin (synthetic) |
1 mg |
| ALX-162-007-MC05 |
Melittin (synthetic) |
0.5 mg |
| ALX-162-009-M001 |
Myelin Basic Protein (4-14) (bovine) |
1 mg |
| ALX-162-009-M005 |
Myelin Basic Protein (4-14) (bovine) |
5 mg |
| ALX-162-010-M001 |
Myelin Basic Protein (104-118) (bovine) |
1 mg |
| ALX-162-010-M005 |
Myelin Basic Protein (104-118) (bovine) |
5 mg |
| ALX-162-011-M001 |
Myosin Light Chain Kinase (11-19) amide |
1 mg |
| ALX-162-011-M005 |
Myosin Light Chain Kinase (11-19) amide |
5 mg |
| ALX-162-012-M001 |
Myosin Light Chain Kinase (342-352) amide |
1 mg |
| ALX-162-012-M005 |
Myosin Light Chain Kinase (342-352) amide |
5 mg |
| ALX-162-013-M001 |
Myosin Light Chain Kinase Substrate |
1 mg |
| ALX-162-013-M005 |
Myosin Light Chain Kinase Substrate |
5 mg |
| ALX-162-016-M001 |
［Pyr4］-Myelin Basic Protein (4-14) (bovine) |
1 mg |
| ALX-162-016-M005 |
［Pyr4］-Myelin Basic Protein (4-14) (bovine) |
5 mg |
| ALX-162-017-M001 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
1 mg |
| ALX-162-017-M005 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
5 mg |
| ALX-162-018-M001 |
N-Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH |
1 mg |
| ALX-162-018-M005 |
N-Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH |
5 mg |
| ALX-162-019-M001 |
［Ala96］-Myelin Basic Protein (87-99) (human, bovine, rat) |
1 mg |
| ALX-162-019-M005 |
［Ala96］-Myelin Basic Protein (87-99) (human, bovine, rat) |
5 mg |
| ALX-162-021-C050 |
Blocking Peptide for?PAb to c-Myc Epitope Tag (Prod. No. ALX-210-208) |
50.micro.g |
| ALX-162-024-1 |
Blocking Peptide for?PAb to Myosin VIIa (mouse) (Prod. No. ALX-210-227) |
1 Vial |
| ALX-162-025-C050 |
Blocking Peptide for?PAb to UCP-3 (Prod. No. ALX-210-238) |
50.micro.g |
| ALX-162-026-C050 |
Blocking Peptide for?PAb to Munc-18 (rat) (Prod. No. ALX-210-247) |
50.micro.g |
| ALX-162-027-C050 |
MALP-2 |
50.micro.g |
| ALX-162-028-C050 |
Blocking Peptide for?PAb to Munc-18 Interacting Protein 3 ［Mint3］ (mouse)?(Prod. No. ALX-210-348) |
50.micro.g |
| ALX-162-029-C100 |
Blocking Peptide for PAb to CCR4 (human) (Prod. No. ALX-210-622) |
100.micro.g |
| ALX-162-030-MC05 |
Myelin Oligodendrocyte Glycoprotein ［MOG］ (35-35) (mouse, rat) |
0.5 mg |
| ALX-162-030-M001 |
Myelin Oligodendrocyte Glycoprotein ［MOG］ (35-35) (mouse, rat) |
1 mg |
| ALX-162-031-M001 |
Myelin Proteolipid Protein ［PLP］ (139-151) (human, bovine, dog, mouse, rat) |
1 mg |
| ALX-162-032-M001 |
［Ser140］-Myelin Proteolipid Protein ［PLP］ (139-151) (human, bovine, dog, mouse, rat) |
1 mg |
| ALX-162-033-M001 |
Myelin Basic Protein ［MBP］ (87-99) (human, bovine, rat) |
1 mg |
| ALX-163-001-P001 |
Nociceptin |
1 mg* |
| ALX-163-001-P005 |
Nociceptin |
5 mg* |
| ALX-163-002-P001 |
Neurotensin |
1 mg* |
| ALX-163-002-P005 |
Neurotensin |
5 mg* |
| ALX-163-003-P001 |
NPY (human) |
1 mg* |
| ALX-163-003-PC05 |
NPY (human) |
0.5 mg* |
| ALX-163-004-M001 |
Neurogranin (28-43) |
1 mg |
| ALX-163-005-C050 |
Blocking Peptide for?PAb to Nitric Oxide Synthase (Inducible) (mouse) (Prod. No. ALX-210-504) |
50.micro.g |
| ALX-163-007-C050 |
Blocking Peptide for PAb to N-CoR (mouse) (Prod. No. ALX-210-254) |
50.micro.g |
| ALX-163-008-C050 |
Blocking Peptide for?PAb to Na+ / Ca2+-K+ Exchanger (rat)?(Prod. No. ALX-210-292) |
50.micro.g |
| ALX-163-009-C050 |
Blocking Peptide for?MAb to Nuclear Factor of Activated T cells, Cytoplasmic 2?(Prod. No. ALX-804-215) |
50.micro.g |
| ALX-163-011-1 |
NBD ［NF-kappaB Blocker］ Peptide (cell permeable) |
1 Vial |
| ALX-163-012-C050 |
Blocking Peptide for PAb to Nitric Oxide Synthase (neuronal) (rat) (phosphorylated) (pSer1416) (Prod. No. ALX-210-528) |
50.micro.g |
| ALX-163-013-C050 |
Blocking Peptide for PAb to Nitric Oxide Synthase (Neuronal) (rat) (Prod. No. ALX-210-529) |
50.micro.g |
| ALX-163-014-C050 |
Blocking Peptide for PAb to Nicastrin (Prod. No. ALX-210-561) |
50.micro.g |
| ALX-164-001-C100 |
Orexin A (human, bovine, rat, mouse) |
100.micro.g |
| ALX-164-001-C500 |
Orexin A (human, bovine, rat, mouse) |
500.micro.g |
| ALX-164-001-M001 |
Orexin A (human, bovine, rat, mouse) |
1 mg |
| ALX-164-002-C100 |
Orexin B (human) |
100.micro.g |
| ALX-164-003-C100 |
Orexin B (rat, mouse) |
100.micro.g |
| ALX-164-004-M001 |
Obestatin (human) |
1 mg |
| ALX-164-004-M005 |
Obestatin (human) |
5 mg |
| ALX-164-005-M001 |
Obestatin (mouse, rat) |
1 mg |
| ALX-164-005-M005 |
Obestatin (mouse, rat) |
5 mg |
| ALX-165-001-M001 |
GP Antagonist-2 |
1 mg |
| ALX-165-001-M005 |
GP Antagonist-2 |
5 mg |
| ALX-165-002-M001 |
［D-Trp7,9,10］-Substance P |
1 mg |
| ALX-165-002-M005 |
［D-Trp7,9,10］-Substance P |
5 mg |
| ALX-165-003-M001 |
PACAP (1-27) (human, sheep, rat) |
1 mg |
| ALX-165-003-MC05 |
PACAP (1-27) (human, sheep, rat) |
0.5 mg |
| ALX-165-004-M001 |
pp60v-src (137-157) |
1 mg |
| ALX-165-004-MC01 |
pp60v-src (137-157) |
0.1 mg |
| ALX-165-005-M001 |
PDGF beta-Receptor (719-723) (Phosphorylated) |
1 mg |
| ALX-165-005-M005 |
PDGF beta-Receptor (719-723) (Phosphorylated) |
5 mg |
| ALX-165-006-M001 |
Peptide epsilon |
1 mg |
| ALX-165-006-M005 |
Peptide epsilon |
5 mg |
| ALX-165-006-MC01 |
Peptide epsilon |
0.1 mg |
| ALX-165-007-M001 |
Phospholipase A2 Activating Peptide |
1 mg |
| ALX-165-007-MC01 |
Phospholipase A2 Activating Peptide |
0.1 mg |
| ALX-165-009-M001 |
Protein Kinase C (19-31) |
1 mg |
| ALX-165-009-M005 |
Protein Kinase C (19-31) |
5 mg |
| ALX-165-010-M001 |
Protein Kinase C (19-36) |
1 mg |
| ALX-165-010-M005 |
Protein Kinase C (19-36) |
5 mg |
| ALX-165-011-MC01 |
Protein Kinase C (530-558) |
0.1 mg |
| ALX-165-013-M001 |
Protein Kinase C Substrate |
1 mg |
| ALX-165-013-M005 |
Protein Kinase C Substrate |
5 mg |
| ALX-165-017-M001 |
［Ser25］-Protein Kinase C (19-31) |
1 mg |
| ALX-165-017-M005 |
［Ser25］-Protein Kinase C (19-31) |
5 mg |
| ALX-165-018-M001 |
Protein Kinase p34cdc2 Substrate |
1 mg |
| ALX-165-019-M001 |
PDGF Fragment (Phosphorylated) (cyclic) |
1 mg |
| ALX-165-019-MC01 |
PDGF Fragment (Phosphorylated) (cyclic) |
0.1 mg |
| ALX-165-020-M001 |
Protein Tyrosine Phosphatase Substrate |
1 mg |
| ALX-165-020-M005 |
Protein Tyrosine Phosphatase Substrate |
5 mg |
| ALX-165-022-M001 |
pp60c-src (521-533) (Phosphorylated) |
1 mg |
| ALX-165-022-M005 |
pp60c-src (521-533) (Phosphorylated) |
5 mg |
| ALX-165-022-MC05 |
pp60c-src (521-533) (Phosphorylated) |
0.5 mg |
| ALX-165-023-M001 |
pp60v-src Fragment |
1 mg |
| ALX-165-023-M005 |
pp60v-src Fragment |
5 mg |
| ALX-165-024-M001 |
PKI-tide |
1 mg |
| ALX-165-024-M005 |
PKI-tide |
5 mg |
| ALX-165-025-M001 |
PACAP (1-38) (human, sheep, rat) |
1 mg |
| ALX-165-025-MC05 |
PACAP (1-38) (human, sheep, rat) |
0.5 mg |
| ALX-165-026-M001 |
PACAP (6-38) (human, sheep, rat) |
1 mg |
| ALX-165-026-MC05 |
PACAP (6-38) (human, sheep, rat) |
0.5 mg |
| ALX-165-027-C050 |
Blocking Peptide for MAb to Progesterone Receptor ［PR］ (Prod. No. ALX-803-007) |
50.micro.g |
| ALX-165-029-C050 |
Blocking Peptide for?PAb to PPARalpha (mouse) (Prod. No. ALX-210-190/1) |
50.micro.g |
| ALX-165-030-C050 |
Blocking Peptide for PAb to PPARdelta (mouse) (Prod. No. ALX-210-191/1) |
50.micro.g |
| ALX-165-031-C050 |
Blocking Peptide for?PAb to PPARgamma2 (Prod. No. ALX-210-192) |
50.micro.g |
| ALX-165-032-C100 |
Blocking Peptide for?PAb to Phosphatidyl-4-phosphate 5-kinase-Igamma (Prod. No. ALX-210-745) |
100.micro.g |
| ALX-165-033-C100 |
Blocking Peptide for?PAb to p56dok-2 (human) (Prod. No. ALX-210-746) |
100.micro.g |
| ALX-165-034-C100 |
Blocking Peptide for?PAb to Phosphoinositide 3-Kinase p110delta (human)?(Prod. No. ALX-210-747) |
100.micro.g |
| ALX-165-035-C050 |
Blocking Peptide for?PAb to Prion Protein (sheep) (Prod. No. ALX-210-200) |
50.micro.g |
| ALX-165-036-C050 |
Blocking Peptide for?PAb to Peroxisomal Membrane Protein 70 (mouse) (Prod. No. ALX-210-205) |
50.micro.g |
| ALX-165-038-C050 |
Blocking Peptide for?PAb to p300 (human) (Prod. No. ALX-210-228) |
50.micro.g |
| ALX-165-039-C050 |
Blocking Peptide for?PAb to Akt?(mouse) (Prod. No. ALX-210-226) |
50.micro.g |
| ALX-165-040-C100 |
Blocking Peptide for?PAb to p51A (Prod. No. ALX-210-768) |
100.micro.g |
| ALX-165-041-C100 |
Blocking Peptide for PAb to p51B (Prod. No. ALX-210-769) |
100.micro.g |
| ALX-165-042-C100 |
Blocking Peptide for PAb to pp36 (human) (Prod. No. ALX-210-770) |
100.micro.g |
| ALX-165-043-C050 |
Blocking Peptide for?PAb to PER1 (mouse) (Prod. No. ALX-210-246) |
50.micro.g |
| ALX-165-044-C050 |
Blocking Peptide for?PAb to PAR-4?(Prod. No. ALX-210-248) |
50.micro.g |
| ALX-165-045-C050 |
Blocking Peptide for?PAb to PSD-93?(rat) (Prod. No. ALX-210-266) |
50.micro.g |
| ALX-165-046-C050 |
Blocking Peptide for MAb?to Prion Protein (Prod. No. ALX-803-042) |
50.micro.g |
| ALX-165-047-C050 |
Blocking Peptide for?PAb to Proteasome Activator?11S (Subunit REGgamma)?(Prod. No. ALX-210-297) |
50.micro.g |
| ALX-165-048-C050 |
Blocking Peptide for?PAb to Proteasome Activator?11S (Subunit?REGalpha) (Prod. No. ALX-210-298) |
50.micro.g |
| ALX-165-049-C050 |
Blocking Peptide for?PAb to Proteasome 20S (Subunit C2) (Prod. No. ALX-210-295) |
50.micro.g |
| ALX-165-050-C050 |
Blocking Peptide for?PAb to Proteasome?19S (Subunit S10B)?(Prod. No. ALX-210-296) |
50.micro.g |
| ALX-165-051-C050 |
Blocking Peptide for?PAb to PICK1 (Prod. No. ALX-210-349) |
50.micro.g |
| ALX-165-052-C500 |
Peptide YY (3-36)?(human) |
500.micro.g |
| ALX-165-053-C050 |
Blocking Peptide for PAb?to Perilipin A (mouse) (Prod. No. ALX-210-358) |
50.micro.g |
| ALX-165-054-C050 |
Blocking Peptide for PAb to Perilipin A/B (mouse) (Prod. No. ALX-210-359) |
50.micro.g |
| ALX-165-055-C050 |
Blocking Peptide for PAb to PPARalpha (mouse)?(phosphorylated) (pSer12) (Prod. No. ALX-210-361) |
50.micro.g |
| ALX-165-056-C050 |
Blocking Peptide for PAb to PPARalpha (mouse)?(phosphorylated) (pSer21) (Prod. No. ALX-210-362) |
50.micro.g |
| ALX-165-057-C200 |
Blocking Peptide for?PAb to PAF Receptor (human) (Prod. No. ALX-210-715) |
200.micro.g |
| ALX-165-066-M002 |
Pam3Cys-Ser-(Lys)4 . trihydrochloride |
2 mg |
| ALX-165-067-1 |
PUMA (135-154) (cell permeable) |
1 Vial |
| ALX-165-068-C050 |
Blocking Peptide for PAb to PDIA6 (human) (Prod. No. ALX-210-889) |
50.micro.g |
| ALX-165-069-M001 |
Pam3CysSK4 (Aca-Aca-Biotin) |
1 mg |
| ALX-166-001-M001 |
Ras Inhibitory Peptide |
1 mg |
| ALX-166-001-M005 |
Ras Inhibitory Peptide |
5 mg |
| ALX-166-002-M001 |
R-R-SRC-Peptide |
1 mg |
| ALX-166-002-M005 |
R-R-SRC-Peptide |
5 mg |
| ALX-166-003-C050 |
Blocking Peptide for?PAb (Prod. No. ALX-210-156)?&?MAb (Prod. No. ALX-804-102) to Retinoic Acid Receptor alpha |
50.micro.g |
| ALX-166-004-C050 |
Blocking Peptide for?PAb (Prod. No. ALX-210-157)?&?MAb (Prod. No. ALX-804-103) to Retinoic Acid Receptor beta |
50.micro.g |
| ALX-166-005-C050 |
Blocking Peptide for?PAb to RIP140?(Prod. No. ALX-210-284) |
50.micro.g |
| ALX-166-006-C050 |
Blocking Peptide for PAb to RbAp46 (human)?(Prod. No. ALX-210-287) |
50.micro.g |
| ALX-166-007-C050 |
Blocking Peptide for?PAb to RbAp48 (human)?(Prod. No. ALX-210-288) |
50.micro.g |
| ALX-166-008-C050 |
Blocking Peptide for?PAb to Rab 3D (mouse) (Prod. No. ALX-210-855) |
50.micro.g |
| ALX-166-009-C050 |
Blocking Peptide for PAb to Resistin (mouse) (Prod. No. ALX-210-357) |
50.micro.g |
| ALX-167-001-P001 |
Sarafotoxin S6b |
1 mg* |
| ALX-167-001-PC01 |
Sarafotoxin S6b |
0.1 mg* |
| ALX-167-001-PC05 |
Sarafotoxin S6b |
0.5 mg* |
| ALX-167-002-P001 |
Sarafotoxin S6c |
1 mg* |
| ALX-167-002-PC01 |
Sarafotoxin S6c |
0.1 mg* |
| ALX-167-002-PC05 |
Sarafotoxin S6c |
0.5 mg* |
| ALX-167-003-M001 |
Substance P |
1 mg |
| ALX-167-003-M005 |
Substance P |
5 mg |
| ALX-167-004-P001 |
Somatostatin-14 |
1 mg* |
| ALX-167-004-P005 |
Somatostatin-14 |
5 mg* |
| ALX-167-006-M001 |
S6 Phosphate Acceptor Peptide |
1 mg |
| ALX-167-006-M005 |
S6 Phosphate Acceptor Peptide |
5 mg |
| ALX-167-007-M001 |
Syntide 2 |
1 mg |
| ALX-167-007-M005 |
Syntide 2 |
5 mg |
| ALX-167-009-M001 |
Sauvagine |
1 mg |
| ALX-167-009-MC05 |
Sauvagine |
0.5 mg |
| ALX-167-010-C050 |
Blocking Peptide for?PAb to Ca2+-Sensing Receptor (Prod. No. ALX-210-143) |
50.micro.g |
| ALX-167-011-C050 |
Blocking Peptide for?PAb to SERCA3 ATPase (Prod. No. ALX-210-167/1) |
50.micro.g |
| ALX-167-016-C050 |
Blocking Peptide for?PAb to SAP97 (rat) (Prod. No. ALX-210-267) |
50.micro.g |
| ALX-167-017-C050 |
Blocking Peptide for?PAb to SAP102 (rat) (Prod. No. ALX-210-268) |
50.micro.g |
| ALX-167-018-C050 |
Blocking Peptide for?PAb to SNAP-25 (Prod. No. ALX-210-279) |
50.micro.g |
| ALX-167-019-C050 |
Blocking Peptide for?MAb to SMRT (human)?(Prod. No. ALX-804-281 & ALX-804-282) |
50.micro.g |
| ALX-167-020-C050 |
Blocking Peptide for?PAb to Steroid Receptor Coactivator-1 (Prod. No. ALX-210-283) |
50.micro.g |
| ALX-167-021-C050 |
Blocking Peptide for?PAb to SAP97 (rat)?(Prod. No. ALX-210-280) |
50.micro.g |
| ALX-167-023-C050 |
Blocking Peptide for PAb to b-Secretase (CT) (Prod. No. ALX-210-281) |
50.micro.g |
| ALX-167-024-C500 |
SN50 |
500.micro.g |
| ALX-167-025-C500 |
SN50M Control Peptide |
500.micro.g |
| ALX-167-026-C050 |
Blocking Peptide for?PAb to SCAMP 1 (rat)?(Prod. No. ALX-210-790) |
50.micro.g |
| ALX-167-027-C050 |
Blocking Peptide for?PAb to SCAMP2 (Prod. No. ALX-210-857) |
50.micro.g |
| ALX-168-003-M001 |
Tyrosine Phosphorylation Site Inhibitor |
1 mg |
| ALX-168-003-M005 |
Tyrosine Phosphorylation Site Inhibitor |
5 mg |
| ALX-168-004-M001 |
H-Tyr-Ile-Tyr-Gly-Ser-Phe-Lys-OH |
1 mg |
| ALX-168-004-M005 |
H-Tyr-Ile-Tyr-Gly-Ser-Phe-Lys-OH |
5 mg |
| ALX-168-005-M001 |
Tyrosine Hydroxylase (24-33) (rat) |
1 mg |
| ALX-168-006-C100 |
Blocking Peptide for PAb to TRAIL-R3 (human) (Prod. No. ALX-210-744) |
100.micro.g |
| ALX-168-007-C100 |
Blocking Peptide for PAb to TRAIL-R2 (Prod. No. ALX-210-743) |
100.micro.g |
| ALX-168-009-R050 |
L-TAT Control Peptide (for Prod. No. ALX-159-600) |
50.micro.l |
| ALX-168-009F-R050 |
L-TAT Control Peptide (for Prod. No. ALX-159-600) |
50.micro.l |
| ALX-168-010-R025 |
D-TAT Control Peptide (for Prod. No. ALX-159-601) |
25.micro.l |
| ALX-168-010F-R025 |
D-TAT Control Peptide (for Prod. No. ALX-159-601) |
25.micro.l |
| ALX-168-011-C100 |
Blocking Peptide for PAb to Toll-like Receptor 2 (human) (Prod. No. ALX-210-852) |
100.micro.g |
| ALX-168-012-C100 |
Blocking Peptide for PAb to Toll-like Receptor 5 (human) (Prod. No. ALX-210-853) |
100.micro.g |
| ALX-170-001-P001 |
Vasoactive Intestinal Contractor (mouse) |
1 mg* |
| ALX-170-001-PC01 |
Vasoactive Intestinal Contractor (mouse) |
0.1 mg* |
| ALX-170-001-PC05 |
Vasoactive Intestinal Contractor (mouse) |
0.5 mg* |
| ALX-170-002-C050 |
Blocking Peptide for?PAb to?Voltage-Dependent Anion Channel (rat) (Prod. No. ALX-210-785) |
50.micro.g |
| ALX-170-003-C050 |
Blocking Peptide for PAb to TRPV1 ［VR1］ (rat) (Prod. No. ALX-210-318) |
50.micro.g |
| ALX-170-004-C050 |
Blocking Peptide for?PAb to VAMP-3 (rat) (Prod. No. ALX-210-854) |
50.micro.g |
| ALX-170-005-C050 |
Blocking Peptide for PAb to TRPV1 ［VR1］ (human) (Prod. No. ALX-210-417) |
50.micro.g |
